Erudio Healtherudio.com
Drug
Pemigatinib trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying pemigatinib: CUPISCO. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 7 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| CUPISCO NCT03498521 · Hoffmann-La Roche | unfavourable cancer of unknown primary | Phase 2 | 358 | 62 | Deep | Oct 31, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| FIGHT-302 NCT03656536 · Incyte Corporation DeepView → | first-line advanced cholangiocarcinoma with FGFR2 rearrangements | Phase 3 | Deep | View | |||
| FIGHT-202 NCT02924376 · Incyte Corporation DeepView → | previously treated locally advanced or metastatic cholangiocarcinoma | Phase 2 | Deep | View | |||
| ROME NCT04591431 · Fondazione per la Medicina Personalizzata DeepView → | advanced solid tumors | Phase 2 | Deep | View | |||
| FIGHT-101 NCT02393248 · Incyte Corporation DeepView → | advanced malignancies | Phase 1/Phase 2 | Deep | View | |||
| FIGHT-201 NCT02872714 · Incyte Corporation FocusedView → | metastatic or unresectable urothelial carcinoma with FGF/FGFR alterations | Phase 2 | Focused | View | |||
| FIGHT-207 NCT03822117 · Incyte Corporation FocusedView → | previously treated solid tumors with activating FGFR1-FGFR3 alterations | Phase 2 | Focused | View | |||
| FIGHT-203 NCT03011372 · Incyte Corporation FocusedView → | myeloid/lymphoid neoplasms with FGFR1 rearrangement | Phase 2 | Focused | View | |||